tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Similar Stocks

Compare
830 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
$189.55
$3.62B
88.14
62.13%
7 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$25.23
$3.12B
84.09
-23.98%
8 Buy
6 Hold
1 Sell
Moderate Buy
Scholar Rock Holding
$46.87
$4.78B
12.53%
11 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$49.31
$4.56B
-5.91%
14 Buy
1 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$89.68
$6.93B
112.66%
21 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$14.79
$1.00B
-71.19%
10 Buy
5 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LGND
Ligand Pharma
189.55
72.64
62.13%
APLS
Apellis Pharmaceuticals
25.23
-7.96
-23.98%
SRRK
Scholar Rock Holding
46.87
4.89
11.65%
CRNX
Crinetics Pharmaceuticals
50.49
-3.17
-5.91%
KYMR
Kymera Therapeutics
89.68
47.55
112.86%
MLTX
MoonLake Immunotherapeutics
14.79
-36.55
-71.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts